GentaGel Overview
GentaGel develops a local slow-release antibiotic treatment, which is injected and continuously releases antibiotics for up to 60 days. The antibiotic is not detectable in circulation but achieves sufficient therapeutic concentrations in the administered area. GentaGel provides an effective antibiotic treatment while avoiding systemic side-effects and expensive cost-of-care. The company is based on a ground-breaking drug delivery technology invented by Prof. Domb, for the in-situ sustained release of antibiotics for the treatment and prevention of surgical site infections.
Latest News
No news articles.
| Sector | Health Tech & Life Sciences |
Funding
| Total funding | Undisclosed |
| Last funding | Undisclosed |
| Stage | Pre-Funding |
| Rounds | 0 |
| Investors | 0 |
Team Members
3
Employees: 1-10
Web & Social Links
| Website | gentagel-lr.com/ |
Locations
HaKalanit St 10, Jerusalem, Israel
Photos & Videos
No files yet
GentaGel Business
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrug DeliveryMedical DevicesMedical Treatment & TherapeuticsTarget Customer
Healthcare & Life SciencesLife SciencesBiotechnologyHealthcareProvidersMedical Devices IndustryMedical ProductsCore Technology
Materials & SubstancesPolymersTags (4)
polymersantibioticspharmaceuticalsinfectionGentaGel Financials
GentaGel Lifecycle
GentaGel News
0 articlesNo news articles.
GentaGel Team
Employee Info
| Employees (range) | 1-10 |
| Exact count | 6 |
| Team members | 3 |
Similar Companies
Similar companies data is computed dynamically and not stored in the entity profile. This section requires implementing a similarity query (e.g. by classification overlap, sector, district).
This entity has 14 classification IDs that could be used for matching.
GentaGel Internal
Recent Updates
No update log entries.
Note: Free-text notes visible in the original Finder "Internal" tab are not present in the imported profile data. Only the update audit log is available.
Admin Info
| Confidence | 86/100 |
| Missing | video or image, funding rounds, news, markets, external profiles, not claimed |
| BI Verification | Yanina Wainscheinker |
| Registrar ID | 516427762 |
| Phone | +972526221662 |
| Creator | Matan Eblagon |
| Creator email | matane@sncentral.org |
| Last updater | Matan Eblagon |
| Updater email | matane@sncentral.org |
| Last update | 2023-08-05T00:00:00.000Z |
| Created | 2023-07-27T00:00:00.000Z |